The U.S. Food and Drug Administration (FDA) has now released detailed data regarding one hundred and forty-four (144) seafood entry line refusals in June, of which ten (6.9%) were for shrimp for reasons related to banned antibiotics.
Through the first half of 2025, the FDA has reported refusing a total of forty-three (43) entry lines of shrimp for reasons related to veterinary drug residues and, as shown in the chart below, is on track to refuse the largest number of entry lines during a calendar year since 2016.
The ten entry lines of shrimp refused for veterinary drug residues in June were attributed to shipments from seven different exporters in China, India, Indonesia, and Vietnam. As noted below, five of these seven exporters are Best Aquaculture Practices (BAP)-certified shrimp processors:
- Chengdu Yuanxian Food Co., Ltd. (China), a company that is not currently included on the “green” list for Import Alert 16-131 (“Detention Without Physical Examination of Aquacultured Shrimp, Dace, and Eel from China and Hong Kong SAR – Presence of New Animal Drugs and/or Unsafe Food Additives”), had one entry line refused for shrimp contaminated with unsafe additives and veterinary drug residues by the Division of West Coast Imports on June 24, 2025;
- Elque & Co (India), a company that is not currently listed on Import Alert 16-124 (“Detention Without Physical Examination of Aquaculture Seafood Products Due to Unapproved Drugs”), Import Alert 16-127 (“Detention Without Physical Examination of All Seafood Due to Chloramphenicol”), or Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”), had four entry lines refused for shrimp that was filthy, contaminated with veterinary drug residues, nitrofurans, and salmonella by the Division of West Coast Imports on June 13, 2025;
- Kalyan Aqua & Marine Exports India Pvt. Ltd. (India), a company that currently operates under a four-star BAP certification for its processing plant (P10352), with additional BAP certifications for a related shrimp farm (F10442B), and that is not currently listed on Import Alert 16-124 (“Detention Without Physical Examination of Aquaculture Seafood Products Due to Unapproved Drugs”), Import Alert 16-127 (“Detention Without Physical Examination of Crustaceans Due to Chloramphenicol”), or Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”), had one entry line refused for shrimp contaminated with nitrofurans by the Division of Northeast Imports on June 17, 2025;
- Falcon Marine Exports Ltd. (India), a company that currently operates under four-star BAP certifications for two processing plants (P10015 and P10647) with additional BAP certifications for over 70 shrimp farms and that was added to Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”) on April 2, 2025 for the presence of nitrofurans in its shrimp, had one entry line refused for shrimp contaminated with veterinary drug residues by the Division of Northeast Imports on June 18, 2025;
- PT. Pabrik Lamongan BMI (Indonesia), a company that currently operates under a four-star BAP certification for its processing plant (P10680) and that was added to Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”) on June 30, 2025 for the presence of nitrofurans in its shrimp, had one entry line refused for shrimp contaminated with veterinary drug residues and nitrofurans by the Division of West Coast Imports on June 4, 2025;
- PT. Tamron Akuatik Produk Industri (Indonesia), a company that currently operates under a four-star BAP certification for its processing plant (P10704) and that is not currently listed on Import Alert 16-124 (“Detention Without Physical Examination of Aquaculture Seafood Products Due to Unapproved Drugs”), Import Alert 16-127 (“Detention Without Physical Examination of Crustaceans Due to Chloramphenicol”), or Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”), had one entry line refused for breaded shrimp contaminated with veterinary drug residues and nitrofurans by the Division of Southeast Imports on June 27, 2025; and
- An Phu Factory – Soc Trang Seafood Joint Stock Company (Stapimex) (Vietnam), a company that currently operates the An Phu factory under a four-star BAP certification (P10326) with an additional BAP certification for another processing plant (P10162) and multiple BAP certifications for related shrimp farms, and that was added to Import Alert 16-124 (“Detention Without Physical Examination of Aquaculture Seafood Products Due to Unapproved Drugs”) on June 26, 2025 for the presence of amoxicillin in its shrimp, had one entry line refused for shrimp contaminated with nitrofurans and veterinary drug residues by the Division of West Coast Imports on June 26, 2025.
Finally, continuing its actions taken each month since February, the FDA refused another entry line from Indonesia’s Mega Marine Pride in June due to deficiencies with the labeling of sulfites that were present in its shrimp.